Aegros
About Us
Revolutionizing Plasma Fractionation for Global Health
Aegros is a pioneering leader in the plasma industry, operating across Australia, Singapore, and the USA. We specialize in the manufacturing, marketing, and development of innovative plasma products derived from human blood. Our mission is driven by the belief that access to life-saving plasma therapies should be a fundamental right for all, not just a privilege. Over the past 30 years, our groundbreaking CyMES (Cylindrical Membrane Electro Separation) process has revolutionized plasma fractionation, enabling countries to achieve self-sufficiency in producing therapeutic plasma products. With a team boasting over a century of collective experience and a portfolio of more than 50 patent families, Aegros is uniquely positioned to deliver complete plasma fractionation solutions—from plasma collection to finished products—especially for emerging markets.
Our Vision
To empower every nation with the ability to produce life-saving plasma therapies, ensuring that access to these critical medical solutions is a universal human right, not a privilege.
Our Vision
To empower every nation with the ability to produce life-saving plasma therapies, ensuring that access to these critical medical solutions is a universal human right, not a privilege.
KNEOWORLD – THE PLATFORM
- Significantly reduces production steps compared to current technology thereby reducing manufacturing costs;
- Eliminates the use of ethanol or other solvents. This provides significant environmental, safety and cost savings.
- Uses electrical field in a cylindrical electrophoresis configuration allowing for selective isolation of plasma proteins;
- High process yield.
- Increased level of protection against pathogen contamination.
- High level of product purity.